TB Research

POS-086 INH INDUCED LACTIC ACIDOSIS IN HEMODIALYSIS PATIENT NOT COMPLIANT WITH HEMODIALYSIS AND PYRIDOXIN

Nihal Bashir, E. Khater

Kidney International Reports · 2022-02

Abstract

Isoniazid is an anti-tuberculosis drug, used commonly for treatment and prophylaxis of tuberculosis. Acute isoniazid intoxication is characterized by a clinical triad consisting of metabolic acidosis resistant to treatment with sodium bicarbonate, seizures which may be fatal and refractory to standard anticonvulsant therapy, and coma. Treatment requires admission to the intensive care unit for ventilatory support, management of seizures and metabolic acidosis. Pyridoxine, in a dose equivalent to the amount of isoniazid ingested, is the only effective antidote.

MeSH terms

  • Medicine
  • Pyridoxine
  • Metabolic acidosis
  • Antidote
  • Coma (optics)
  • Isoniazid
  • Sodium bicarbonate
  • Hemodialysis
  • Lactic acidosis
  • Acidosis
  • Anesthesia
  • Intensive care medicine
  • Refractory (planetary science)
  • Tuberculosis
  • Internal medicine